ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sanofi's Sarclisa bags NICE recommendation
October 19, 2020French pharma Sanofi’s Sarclisa has been granted a positive recommendation from the National Institute for Health and Care (NICE) for patients with multiple myeloma. -
NICE rejects Sanofi's Sarclisa in preliminary guidelines
June 09, 2020NICE has published initial guidelines rejecting NHS use of a therapy combination containing Sanofi's Sarclisa (isatuximab) to treat multiple myeloma. -
Sanofi secures EC approval for Sarclisa for third-line multiple myeloma
June 08, 2020Sanofi has secured approval from the European Commission (EC) for Sarclisa (isatuximab) in combination with pomalidomide and dexamethasone (pom-dex) for the treatment of relapsed and refractory multiple myeloma (MM) in adult patients.
Pharma Sources Insight January 2025
